CIK 0001581280
- Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462058888
- Phone
- +1 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $99,863,292
- in 32 filings, $84.3M under 10b5-1 plans
Net −$99,863,292. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Leproust Emily M. Chief Executive Officer | Sale | −4,573 | $135.40 | $619K | 558,187 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −1,840 | $200.44 | $369K | 565,468 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −481 | $201.26 | $97K | 564,987 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −1,017 | $202.32 | $206K | 563,970 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −432 | $203.61 | $88K | 563,538 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −290 | $204.80 | $59K | 563,248 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −297 | $205.78 | $61K | 562,951 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −146 | $206.84 | $30K | 562,805 |
| 2026-10-05 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −45 | $207.46 | $9K | 562,760 |
| 2026-10-02 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −45,736 | $188.88 | $8.6M | 567,308 |
| 2026-10-01 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −655 | $200.00 | $131K | 613,044 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −2,485 | $175.23 | $435K | 616,417 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −945 | $176.39 | $167K | 615,472 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −164 | $177.17 | $29K | 615,308 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −330 | $178.67 | $59K | 614,978 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −143 | $179.93 | $26K | 614,835 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −515 | $180.39 | $93K | 614,320 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −21 | $181.45 | $4K | 614,299 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −16 | $182.50 | $3K | 614,283 |
| 2026-09-24 | Leproust Emily M. Chief Executive Officer | Sale 10b5-1 | −501 | $183.76 | $92K | 613,782 |
Page 1 of 5 · 97 trades